APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olaparib Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Olaparib Tablets Industry Growth and Trends Forecast to 2032

27 December 2025104 pages

Choose your research edition.

Industry ResearchOlaparib Tablets Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Olaparib Tablets Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Olaparib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olaparib Tablets Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Olaparib Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Olaparib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Olaparib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Olaparib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Olaparib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Olaparib Tablets include CSPC Ouyi Pharmaceutical, Qilu Pharmaceutical, Merck, Kelun Pharmaceutical, Sino Therapeutics, Jiangsu Litaier Pharmaceuticals, Huadong Medicin, Natco Pharma and Everest Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Olaparib Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Olaparib Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Olaparib Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Olaparib Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Olaparib Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Olaparib Tablets Market by Company

CSPC Ouyi Pharmaceutical

Qilu Pharmaceutical

Merck

Kelun Pharmaceutical

Sino Therapeutics

Jiangsu Litaier Pharmaceuticals

Huadong Medicin

Natco Pharma

Everest Pharmaceuticals

BDR Pharmaceuticals

AstraZeneca

Olaparib Tablets Segment by Type

100mg per Tablet

500mg per Tablet

Olaparib Tablets Segment by Application

Ovarian Cancer

Breast Cancer

Metastatic Prostate Cancer

Metastatic Pancreatic Cancer

Olaparib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olaparib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olaparib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olaparib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Olaparib Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Olaparib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg per Tablet Table 2. Major Company of 500mg per Tablet Table 3. Global Olaparib Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Olaparib Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Olaparib Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Olaparib Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Olaparib Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Olaparib Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Olaparib Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Olaparib Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Olaparib Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Olaparib Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Olaparib Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Olaparib Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Olaparib Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Olaparib Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Olaparib Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Olaparib Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Olaparib Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Olaparib Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Olaparib Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Olaparib Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Olaparib Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Olaparib Tablets Industry Trends Table 25. Olaparib Tablets Industry Drivers Table 26. Olaparib Tablets Industry Opportunities and Challenges Table 27. Olaparib Tablets Industry Restraints Table 28. Global Olaparib Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Olaparib Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Olaparib Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Olaparib Tablets Sales Share by Company (2021-2026) Table 32. Global Olaparib Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Olaparib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Olaparib Tablets Major Company Production Sites and Headquarters Table 35. Global Olaparib Tablets Company, Product Type & Application Table 36. Global Olaparib Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Olaparib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Olaparib Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Olaparib Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Olaparib Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Olaparib Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Olaparib Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Olaparib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Olaparib Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Olaparib Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Olaparib Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Olaparib Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Olaparib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Olaparib Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Olaparib Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Olaparib Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Olaparib Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Olaparib Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Olaparib Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Olaparib Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Olaparib Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Olaparib Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Olaparib Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Olaparib Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Olaparib Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Olaparib Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Olaparib Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Olaparib Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Olaparib Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Olaparib Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Olaparib Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Olaparib Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Olaparib Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Olaparib Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. CSPC Ouyi Pharmaceutical Company Information Table 72. CSPC Ouyi Pharmaceutical Business Overview Table 73. CSPC Ouyi Pharmaceutical Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. CSPC Ouyi Pharmaceutical Olaparib Tablets Product Portfolio Table 75. CSPC Ouyi Pharmaceutical Recent Development Table 76. Qilu Pharmaceutical Company Information Table 77. Qilu Pharmaceutical Business Overview Table 78. Qilu Pharmaceutical Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Qilu Pharmaceutical Olaparib Tablets Product Portfolio Table 80. Qilu Pharmaceutical Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck Olaparib Tablets Product Portfolio Table 85. Merck Recent Development Table 86. Kelun Pharmaceutical Company Information Table 87. Kelun Pharmaceutical Business Overview Table 88. Kelun Pharmaceutical Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Kelun Pharmaceutical Olaparib Tablets Product Portfolio Table 90. Kelun Pharmaceutical Recent Development Table 91. Sino Therapeutics Company Information Table 92. Sino Therapeutics Business Overview Table 93. Sino Therapeutics Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sino Therapeutics Olaparib Tablets Product Portfolio Table 95. Sino Therapeutics Recent Development Table 96. Jiangsu Litaier Pharmaceuticals Company Information Table 97. Jiangsu Litaier Pharmaceuticals Business Overview Table 98. Jiangsu Litaier Pharmaceuticals Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jiangsu Litaier Pharmaceuticals Olaparib Tablets Product Portfolio Table 100. Jiangsu Litaier Pharmaceuticals Recent Development Table 101. Huadong Medicin Company Information Table 102. Huadong Medicin Business Overview Table 103. Huadong Medicin Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Huadong Medicin Olaparib Tablets Product Portfolio Table 105. Huadong Medicin Recent Development Table 106. Natco Pharma Company Information Table 107. Natco Pharma Business Overview Table 108. Natco Pharma Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Natco Pharma Olaparib Tablets Product Portfolio Table 110. Natco Pharma Recent Development Table 111. Everest Pharmaceuticals Company Information Table 112. Everest Pharmaceuticals Business Overview Table 113. Everest Pharmaceuticals Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Everest Pharmaceuticals Olaparib Tablets Product Portfolio Table 115. Everest Pharmaceuticals Recent Development Table 116. BDR Pharmaceuticals Company Information Table 117. BDR Pharmaceuticals Business Overview Table 118. BDR Pharmaceuticals Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. BDR Pharmaceuticals Olaparib Tablets Product Portfolio Table 120. BDR Pharmaceuticals Recent Development Table 121. AstraZeneca Company Information Table 122. AstraZeneca Business Overview Table 123. AstraZeneca Olaparib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. AstraZeneca Olaparib Tablets Product Portfolio Table 125. AstraZeneca Recent Development Table 126. North America Olaparib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Olaparib Tablets Sales by Country (2021-2026) & (K Units) Table 128. North America Olaparib Tablets Sales Market Share by Country (2021-2026) Table 129. North America Olaparib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Olaparib Tablets Sales Market Share Forecast by Country (2027-2032) Table 131. North America Olaparib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Olaparib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Olaparib Tablets Market Share by Country (2021-2026) Table 134. North America Olaparib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Olaparib Tablets Market Share Forecast by Country (2027-2032) Table 136. Europe Olaparib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Olaparib Tablets Sales by Country (2021-2026) & (K Units) Table 138. Europe Olaparib Tablets Sales Market Share by Country (2021-2026) Table 139. Europe Olaparib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Olaparib Tablets Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Olaparib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Olaparib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Olaparib Tablets Market Share by Country (2021-2026) Table 144. Europe Olaparib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Olaparib Tablets Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Olaparib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Olaparib Tablets Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Olaparib Tablets Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Olaparib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Olaparib Tablets Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Olaparib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Olaparib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Olaparib Tablets Market Share by Country (2021-2026) Table 154. Asia-Pacific Olaparib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Olaparib Tablets Market Share Forecast by Country (2027-2032) Table 156. Latin America Olaparib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Olaparib Tablets Sales by Country (2021-2026) & (K Units) Table 158. Latin America Olaparib Tablets Sales Market Share by Country (2021-2026) Table 159. Latin America Olaparib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Olaparib Tablets Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Olaparib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Olaparib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Olaparib Tablets Market Share by Country (2021-2026) Table 164. Latin America Olaparib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Olaparib Tablets Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Olaparib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Olaparib Tablets Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Olaparib Tablets Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Olaparib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Olaparib Tablets Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Olaparib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Olaparib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Olaparib Tablets Market Share by Country (2021-2026) Table 174. Middle East and Africa Olaparib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Olaparib Tablets Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Olaparib Tablets Distributors List Table 179. Olaparib Tablets Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Olaparib Tablets Image Figure 2. Global Olaparib Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olaparib Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Olaparib Tablets Sales (2021-2032) & (K Units) Figure 5. 100mg per Tablet Image Figure 6. Global 100mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 500mg per Tablet Image Figure 8. Global 500mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Olaparib Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Olaparib Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Olaparib Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Olaparib Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Olaparib Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Olaparib Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Olaparib Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Olaparib Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Olaparib Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Olaparib Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Olaparib Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Olaparib Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Olaparib Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Ovarian Cancer Image Figure 24. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Breast Cancer Image Figure 26. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Metastatic Prostate Cancer Image Figure 28. Global Metastatic Prostate Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Metastatic Pancreatic Cancer Image Figure 30. Global Metastatic Pancreatic Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Olaparib Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Olaparib Tablets Market Share by Application 2025 VS 2032 Figure 33. North America Olaparib Tablets Sales Market Share in Volume by Application in 2025 Figure 34. North America Olaparib Tablets Sales Market Share in Value by Application in 2025 Figure 35. Europe Olaparib Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Europe Olaparib Tablets Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Olaparib Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Olaparib Tablets Sales Market Share in Value by Application in 2025 Figure 39. Latin America Olaparib Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Olaparib Tablets Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Olaparib Tablets Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Olaparib Tablets Sales Market Share in Value by Application in 2025 Figure 43. North America Olaparib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Olaparib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Olaparib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Olaparib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Olaparib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Olaparib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Olaparib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Olaparib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Olaparib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Olaparib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Olaparib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Olaparib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Olaparib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Olaparib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Olaparib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Olaparib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Olaparib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Olaparib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Olaparib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Olaparib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Olaparib Tablets Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Olaparib Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 500mg per Tablet
Applications
  • Ovarian Cancer
  • Breast Cancer
  • Metastatic Prostate Cancer
  • Metastatic Pancreatic Cancer
Companies covered
  • CSPC Ouyi Pharmaceutical
  • Qilu Pharmaceutical
  • Merck
  • Kelun Pharmaceutical
  • Sino Therapeutics
  • Jiangsu Litaier Pharmaceuticals
  • Huadong Medicin
  • Natco Pharma
  • Everest Pharmaceuticals
  • BDR Pharmaceuticals
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Olaparib Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Olaparib Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Olaparib Tablets Market by Type
  6. 1.3.1 100mg per Tablet
  7. 1.3.2 500mg per Tablet
  8. 1.4 Global Olaparib Tablets Market Size by Type
  9. 1.4.1 Global Olaparib Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Olaparib Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Olaparib Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Olaparib Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Olaparib Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Olaparib Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Olaparib Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Olaparib Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Olaparib Tablets Industry Trends
  2. 2.2 Olaparib Tablets Industry Drivers
  3. 2.3 Olaparib Tablets Industry Opportunities and Challenges
  4. 2.4 Olaparib Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Olaparib Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Olaparib Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Olaparib Tablets Price (2021-2026)
  4. 3.4 Global Olaparib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Olaparib Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Olaparib Tablets Company, Product Type & Application
  7. 3.7 Global Olaparib Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Olaparib Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Olaparib Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Olaparib Tablets Tier 1, Tier 2, and Tier 3
4 Olaparib Tablets Regional Status and Outlook
  1. 4.1 Global Olaparib Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Olaparib Tablets Historic Market Size by Region
  3. 4.2.1 Global Olaparib Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Olaparib Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Olaparib Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Olaparib Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Olaparib Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Olaparib Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Olaparib Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Olaparib Tablets by Application
  1. 5.1 Olaparib Tablets Market by Application
  2. 5.1.1 Ovarian Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Metastatic Prostate Cancer
  5. 5.1.4 Metastatic Pancreatic Cancer
  6. 5.2 Global Olaparib Tablets Market Size by Application
  7. 5.2.1 Global Olaparib Tablets Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Olaparib Tablets Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Olaparib Tablets Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Olaparib Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Olaparib Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Olaparib Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Olaparib Tablets Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Olaparib Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSPC Ouyi Pharmaceutical
  2. 6.1.1 CSPC Ouyi Pharmaceutical Company Information
  3. 6.1.2 CSPC Ouyi Pharmaceutical Business Overview
  4. 6.1.3 CSPC Ouyi Pharmaceutical Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSPC Ouyi Pharmaceutical Olaparib Tablets Product Portfolio
  6. 6.1.5 CSPC Ouyi Pharmaceutical Recent Developments
  7. 6.2 Qilu Pharmaceutical
  8. 6.2.1 Qilu Pharmaceutical Company Information
  9. 6.2.2 Qilu Pharmaceutical Business Overview
  10. 6.2.3 Qilu Pharmaceutical Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical Olaparib Tablets Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Olaparib Tablets Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Kelun Pharmaceutical
  20. 6.4.1 Kelun Pharmaceutical Company Information
  21. 6.4.2 Kelun Pharmaceutical Business Overview
  22. 6.4.3 Kelun Pharmaceutical Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kelun Pharmaceutical Olaparib Tablets Product Portfolio
  24. 6.4.5 Kelun Pharmaceutical Recent Developments
  25. 6.5 Sino Therapeutics
  26. 6.5.1 Sino Therapeutics Company Information
  27. 6.5.2 Sino Therapeutics Business Overview
  28. 6.5.3 Sino Therapeutics Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sino Therapeutics Olaparib Tablets Product Portfolio
  30. 6.5.5 Sino Therapeutics Recent Developments
  31. 6.6 Jiangsu Litaier Pharmaceuticals
  32. 6.6.1 Jiangsu Litaier Pharmaceuticals Company Information
  33. 6.6.2 Jiangsu Litaier Pharmaceuticals Business Overview
  34. 6.6.3 Jiangsu Litaier Pharmaceuticals Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Litaier Pharmaceuticals Olaparib Tablets Product Portfolio
  36. 6.6.5 Jiangsu Litaier Pharmaceuticals Recent Developments
  37. 6.7 Huadong Medicin
  38. 6.7.1 Huadong Medicin Company Information
  39. 6.7.2 Huadong Medicin Business Overview
  40. 6.7.3 Huadong Medicin Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Huadong Medicin Olaparib Tablets Product Portfolio
  42. 6.7.5 Huadong Medicin Recent Developments
  43. 6.8 Natco Pharma
  44. 6.8.1 Natco Pharma Company Information
  45. 6.8.2 Natco Pharma Business Overview
  46. 6.8.3 Natco Pharma Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Natco Pharma Olaparib Tablets Product Portfolio
  48. 6.8.5 Natco Pharma Recent Developments
  49. 6.9 Everest Pharmaceuticals
  50. 6.9.1 Everest Pharmaceuticals Company Information
  51. 6.9.2 Everest Pharmaceuticals Business Overview
  52. 6.9.3 Everest Pharmaceuticals Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Everest Pharmaceuticals Olaparib Tablets Product Portfolio
  54. 6.9.5 Everest Pharmaceuticals Recent Developments
  55. 6.10 BDR Pharmaceuticals
  56. 6.10.1 BDR Pharmaceuticals Company Information
  57. 6.10.2 BDR Pharmaceuticals Business Overview
  58. 6.10.3 BDR Pharmaceuticals Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 BDR Pharmaceuticals Olaparib Tablets Product Portfolio
  60. 6.10.5 BDR Pharmaceuticals Recent Developments
  61. 6.11 AstraZeneca
  62. 6.11.1 AstraZeneca Company Information
  63. 6.11.2 AstraZeneca Business Overview
  64. 6.11.3 AstraZeneca Olaparib Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 AstraZeneca Olaparib Tablets Product Portfolio
  66. 6.11.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America Olaparib Tablets Sales by Country
  2. 7.1.1 North America Olaparib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Olaparib Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Olaparib Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Olaparib Tablets Market Size by Country
  6. 7.2.1 North America Olaparib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Olaparib Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Olaparib Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Olaparib Tablets Sales by Country
  2. 8.1.1 Europe Olaparib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Olaparib Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Olaparib Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Olaparib Tablets Market Size by Country
  6. 8.2.1 Europe Olaparib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Olaparib Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Olaparib Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Olaparib Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Olaparib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Olaparib Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Olaparib Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Olaparib Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Olaparib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Olaparib Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Olaparib Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Olaparib Tablets Sales by Country
  2. 10.1.1 South America Olaparib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Olaparib Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Olaparib Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Olaparib Tablets Market Size by Country
  6. 10.2.1 South America Olaparib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Olaparib Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Olaparib Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Olaparib Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Olaparib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Olaparib Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Olaparib Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Olaparib Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Olaparib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Olaparib Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Olaparib Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Olaparib Tablets Value Chain Analysis
  2. 12.1.1 Olaparib Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Olaparib Tablets Production Mode & Process
  7. 12.2 Olaparib Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Olaparib Tablets Distributors
  10. 12.2.3 Olaparib Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst